ATAC-seq

Map genome-wide chromatin accessibility, revealing regulatory regions and active DNA elements

Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) is a powerful method for profiling open chromatin regions across the genome. By leveraging a hyperactive Tn5 transposase, ATAC-seq integrates sequencing adapters directly into accessible DNA, enabling researchers to map regulatory elements such as promoters, enhancers, and transcription factor binding sites with high sensitivity and low input requirements.

At Admera, our ATAC-seq services provide comprehensive insights into chromatin dynamics to support projects in gene regulation, epigenetic research, and drug discovery. With optimized protocols, rigorous QC, and expert bioinformatics support, we deliver high-resolution data that helps researchers understand how chromatin accessibility shapes gene expression and cellular states.

What is ATAC-seq?

Applications

Cell-type specific chromatin landscapes

Distinguish regulatory elements across tissues, developmental stages, or disease states

Biomarker & Therapeutic Target Discovery

Detect accessible regions associated with disease phenotypes or treatment responses.

Cancer Research

Identify tumor-specific regulatory elements and uncover mechanisms of oncogene activation or tumor suppressor silencing.

Utilize ATAC-seq with single-cell RNA-seq to simultaneously capture chromatin access

Single-cell epigenome profiling

Frequently Asked Questions

Sending samples? See our DNA sample submission guidelines for best practices on sample preparation, packaging, and shipment for the highest quality results.

Get the Most out of Your Study

Maximize your project’s potential with advanced analysis solutions. Our team of expert bioinformaticians curate pipelines tailored to your project’s experimental design.

See ATAC-seq in Action
Admera Health provides comprehensive support for all projects, and delivers publication-ready data. Discover how researchers are using Admera Health to advance their studies.